BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 22611259)

  • 1. Arf6 negatively controls the rapid recycling of the β2 adrenergic receptor.
    Macia E; Partisani M; Paleotti O; Luton F; Franco M
    J Cell Sci; 2012 Sep; 125(Pt 17):4026-35. PubMed ID: 22611259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors.
    Anborgh PH; Seachrist JL; Dale LB; Ferguson SS
    Mol Endocrinol; 2000 Dec; 14(12):2040-53. PubMed ID: 11117533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.
    Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ
    J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cardiac contractility by Rab4-modulated beta2-adrenergic receptor recycling.
    Odley A; Hahn HS; Lynch RA; Marreez Y; Osinska H; Robbins J; Dorn GW
    Proc Natl Acad Sci U S A; 2004 May; 101(18):7082-7. PubMed ID: 15105445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ARF6 regulates angiotensin II type 1 receptor endocytosis by controlling the recruitment of AP-2 and clathrin.
    Poupart ME; Fessart D; Cotton M; Laporte SA; Claing A
    Cell Signal; 2007 Nov; 19(11):2370-8. PubMed ID: 17719203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Arrestin-mediated ADP-ribosylation factor 6 activation and beta 2-adrenergic receptor endocytosis.
    Claing A; Chen W; Miller WE; Vitale N; Moss J; Premont RT; Lefkowitz RJ
    J Biol Chem; 2001 Nov; 276(45):42509-13. PubMed ID: 11533043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ADP ribosylation factor nucleotide exchange factor ARNO promotes beta-arrestin release necessary for luteinizing hormone/choriogonadotropin receptor desensitization.
    Mukherjee S; Gurevich VV; Jones JC; Casanova JE; Frank SR; Maizels ET; Bader MF; Kahn RA; Palczewski K; Aktories K; Hunzicker-Dunn M
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5901-6. PubMed ID: 10811902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive oxygen species are required for β2 adrenergic receptor-β-arrestin interactions and signaling to ERK1/2.
    Singh M; Moniri NH
    Biochem Pharmacol; 2012 Sep; 84(5):661-9. PubMed ID: 22728070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor.
    Goodman OB; Krupnick JG; Santini F; Gurevich VV; Penn RB; Gagnon AW; Keen JH; Benovic JL
    Nature; 1996 Oct; 383(6599):447-50. PubMed ID: 8837779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin type 1A receptor regulates β-arrestin binding of the β
    Tóth AD; Gyombolai P; Szalai B; Várnai P; Turu G; Hunyady L
    Mol Cell Endocrinol; 2017 Feb; 442():113-124. PubMed ID: 27908837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The α-Arrestin ARRDC3 Regulates the Endosomal Residence Time and Intracellular Signaling of the β2-Adrenergic Receptor.
    Tian X; Irannejad R; Bowman SL; Du Y; Puthenveedu MA; von Zastrow M; Benovic JL
    J Biol Chem; 2016 Jul; 291(28):14510-25. PubMed ID: 27226565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A central role for beta-arrestins and clathrin-coated vesicle-mediated endocytosis in beta2-adrenergic receptor resensitization. Differential regulation of receptor resensitization in two distinct cell types.
    Zhang J; Barak LS; Winkler KE; Caron MG; Ferguson SS
    J Biol Chem; 1997 Oct; 272(43):27005-14. PubMed ID: 9341139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rab11 regulates the recycling and lysosome targeting of beta2-adrenergic receptors.
    Moore RH; Millman EE; Alpizar-Foster E; Dai W; Knoll BJ
    J Cell Sci; 2004 Jul; 117(Pt 15):3107-17. PubMed ID: 15190120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD13 tethers the IQGAP1-ARF6-EFA6 complex to the plasma membrane to promote ARF6 activation, β1 integrin recycling, and cell migration.
    Ghosh M; Lo R; Ivic I; Aguilera B; Qendro V; Devarakonda C; Shapiro LH
    Sci Signal; 2019 Apr; 12(579):. PubMed ID: 31040262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Arrestin-mediated Angiotensin II Signaling Controls the Activation of ARF6 Protein and Endocytosis in Migration of Vascular Smooth Muscle Cells.
    Charles R; Namkung Y; Cotton M; Laporte SA; Claing A
    J Biol Chem; 2016 Feb; 291(8):3967-81. PubMed ID: 26703465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gαs is dispensable for β-arrestin coupling but dictates GRK selectivity and is predominant for gene expression regulation by β2-adrenergic receptor.
    Burghi V; Paradis JS; Officer A; Adame-Garcia SR; Wu X; Matthees ESF; Barsi-Rhyne B; Ramms DJ; Clubb L; Acosta M; Tamayo P; Bouvier M; Inoue A; von Zastrow M; Hoffmann C; Gutkind JS
    J Biol Chem; 2023 Nov; 299(11):105293. PubMed ID: 37774973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-arrestin2 enhances beta2-adrenergic receptor-mediated nuclear translocation of ERK.
    Kobayashi H; Narita Y; Nishida M; Kurose H
    Cell Signal; 2005 Oct; 17(10):1248-53. PubMed ID: 16038799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in endosomal targeting of human (beta)1- and (beta)2-adrenergic receptors following clathrin-mediated endocytosis.
    Liang W; Curran PK; Hoang Q; Moreland RT; Fishman PH
    J Cell Sci; 2004 Feb; 117(Pt 5):723-34. PubMed ID: 14734649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential requirements of arrestin-3 and clathrin for ligand-dependent and -independent internalization of human G protein-coupled receptor 40.
    Qian J; Wu C; Chen X; Li X; Ying G; Jin L; Ma Q; Li G; Shi Y; Zhang G; Zhou N
    Cell Signal; 2014 Nov; 26(11):2412-23. PubMed ID: 25038452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta-arrestin complex.
    Naga Prasad SV; Laporte SA; Chamberlain D; Caron MG; Barak L; Rockman HA
    J Cell Biol; 2002 Aug; 158(3):563-75. PubMed ID: 12163475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.